170 related articles for article (PubMed ID: 4060364)
1. Urinary modified nucleosides as tumor markers in cancer of the urinary organs or female genital tract.
Koshida K; Harmenberg J; Stendahl U; Wahren B; Borgström E; Helström L; Andersson L
Urol Res; 1985; 13(5):213-8. PubMed ID: 4060364
[TBL] [Abstract][Full Text] [Related]
2. Gas chromatography/mass spectrometric analysis of urinary nucleosides in cancer patients; potential of modified nucleosides as tumour markers.
Langridge JI; McClure TD; el-Shakawi S; Fielding A; Schram KH; Newton RP
Rapid Commun Mass Spectrom; 1993 Jun; 7(6):427-34. PubMed ID: 8329765
[TBL] [Abstract][Full Text] [Related]
3. Relationship between urinary excretion of modified nucleosides and rheumatoid arthritis process.
Tebib JG; Reynaud C; Cedoz JP; Letroublon MC; Niveleau A
Br J Rheumatol; 1997 Sep; 36(9):990-5. PubMed ID: 9376997
[TBL] [Abstract][Full Text] [Related]
4. [Application of urinary nucleosides in the diagnosis and surgical monitoring of colorectal cancer].
Feng B; Zheng MH; Zheng YF; Lu AG; Li JW; Wang ML; Ma JJ; Xu GW; Yu BM
Zhonghua Wai Ke Za Zhi; 2005 May; 43(9):564-8. PubMed ID: 15938925
[TBL] [Abstract][Full Text] [Related]
5. Biological markers in breast carcinoma--clinical correlations with pseudouridine, N2,N2-dimethylguanosine, and 1-methylinosine.
Tormey DC; Waalkes TP; Gehrke CW
J Surg Oncol; 1980; 14(3):267-73. PubMed ID: 7392649
[TBL] [Abstract][Full Text] [Related]
6. Quantitation of urinary nucleosides by high-performance liquid chromatography.
Liebich HM; Di Stefano C; Wixforth A; Schmid HR
J Chromatogr A; 1997 Feb; 763(1-2):193-7. PubMed ID: 9129323
[TBL] [Abstract][Full Text] [Related]
7. A quantitative approach to determining disease response during therapy using multiple biologic markers: application to carcinoma of the breast.
Woo KB; Waalkes TP; Ahmann DL; Tormey DC; Gehrke CW; Oliverio VT
Cancer; 1978 May; 41(5):1685-703. PubMed ID: 348295
[TBL] [Abstract][Full Text] [Related]
8. Urinary excretion of modified nucleosides in chronic myelogenous leukemia.
Heldman DA; Grever MR; Speicher CE; Trewyn RW
J Lab Clin Med; 1983 May; 101(5):783-92. PubMed ID: 6572681
[TBL] [Abstract][Full Text] [Related]
9. High-performance liquid chromatographic separation and quantitation of nucleosides in urine and some other biological fluids.
Davis GE; Suits RD; Kuo KC; Gehrke CW; Waalkes TP; Borek E
Clin Chem; 1977 Aug; 23(8):1427-35. PubMed ID: 872405
[No Abstract] [Full Text] [Related]
10. Nucleoside excretion in breast cancer: comparison with other biochemical tumour-index-substances.
Coombes RC; Powles TJ; Gehrke CW; Waalkes TP; Neville AM
Invest Cell Pathol; 1979; 2(1):11-4. PubMed ID: 511604
[TBL] [Abstract][Full Text] [Related]
11. The urinary excretion of nucleosides of ribonucleic acid by patients with advanced cancer.
Waalkes TP; Gehrke CW; Zumwalt RW; Chang SY; Lakings DB; Tormey DC; Ahmann DL; Moertel CG
Cancer; 1975 Aug; 36(2):390-8. PubMed ID: 1157009
[TBL] [Abstract][Full Text] [Related]
12. Relationship of urinary excretion of modified nucleosides to disease status in childhood acute lymphoblastic leukemia.
Heldman DA; Grever MR; Miser JS; Trewyn RW
J Natl Cancer Inst; 1983 Aug; 71(2):269-73. PubMed ID: 6576186
[TBL] [Abstract][Full Text] [Related]
13. Differential excretion of modified nucleosides in adult acute leukemia.
Heldman DA; Grever MR; Trewyn RW
Blood; 1983 Feb; 61(2):291-6. PubMed ID: 6571786
[TBL] [Abstract][Full Text] [Related]
14. Urinary excretion by cancer patients of the nucleosides N-dimethylguanosine, 1-methylinosine, and pseudouridine.
Waalkes TP; Dinsmore SR; Mrochek JE
J Natl Cancer Inst; 1973 Jul; 51(1):271-4. PubMed ID: 4720877
[No Abstract] [Full Text] [Related]
15. Creatinine at the evaluation of urinary 1-methyladenosine and pseudouridine excretion.
Honda I; Itoh K; Mizugaki M; Sasaki T
Tohoku J Exp Med; 1999 Jun; 188(2):133-8. PubMed ID: 10526874
[TBL] [Abstract][Full Text] [Related]
16. The urinary excretion of the nucleosides pseudouridine and 1-methylinosine during normal menstrual cycle.
Lehtiö H; Mäenpää PH
Clin Chim Acta; 1977 Oct; 80(1):181-5. PubMed ID: 908140
[TBL] [Abstract][Full Text] [Related]
17. Biochemically detectable tumor markers in urine of bladder cancer patients.
Irving CC
Cancer Res; 1977 Aug; 37(8 Pt 2):2872-4. PubMed ID: 872116
[TBL] [Abstract][Full Text] [Related]
18. Statistical-based approach in potential diagnostic application of urinary nucleosides in urogenital tract cancer.
Daghir-Wojtkowiak E; Struck-Lewicka W; Waszczuk-Jankowska M; Markuszewski M; Kaliszan R; Markuszewski MJ
Biomark Med; 2015; 9(6):577-95. PubMed ID: 26079962
[TBL] [Abstract][Full Text] [Related]
19. [Significance of urinary nucleosides in diagnosis of gastric carcinoma].
Chen YJ; Zheng YF; Wang NF; Lu S; Pang T; Yang Q; Xu GW
Ai Zheng; 2003 May; 22(5):537-40. PubMed ID: 12753721
[TBL] [Abstract][Full Text] [Related]
20. [Excretion of methylated nucleosides in the initial therapy phase in a case of anorexia nervosa].
Clemens P; Schöch G; Ziemer G; Altenhoff J; Erb N; Lorenz H; Müller J; Grüttner R
Padiatr Padol; 1982; 17(2):157-63. PubMed ID: 7099674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]